Clinical trial
Normobaric Oxygen Therapy in Acute Ischemic Stroke Trial
NCT00414726 · Massachusetts General Hospital, Other · Terminated
Key facts
| NCT number | NCT00414726 |
|---|---|
| Title | Normobaric Oxygen Therapy in Acute Ischemic Stroke Trial |
| Official title | Clinical Trial of Normobaric Oxygen Therapy in Acute Ischemic Stroke |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ischemic Stroke |
| Intervention type | Drug |
| Interventions | NBO (Normobaric Oxygen), Room Air |
| Enrollment | 85 |
| Start date | Jan 1, 2007 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Dec 22, 2006 |
| Last update posted | Oct 20, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: